US-based AliveCor has obtained CE mark approval for its automated analysis process (algorithm) to detect atrial fibrillation (AF), the most common cause of stroke.


The latest version of the AliveECG app will allow patients in the UK and Ireland, to detect AF in electrocardiogram (ECG) recordings using the AliveCor Heart Monitor.

The new AF Detector is said to analyse each ECG recorded, as well as automatically notifies the user if AF is detected in that ECG, noted AliveCor.

AliveCor president and CEO Euan Thomson said: "The UK and Ireland make up more than 20% of our customers and we are excited to now be able to share the AF Detector with them as a powerful tool to help manage their heart conditions.

"The AF Detector, and our continued efforts to support the local community with screening for AF, reconfirm our goal of providing patients and caregivers with clinical-quality, mobile health technology and analysis that can improve heart health."

The AliveCor Heart Monitor has been developed to record, store and transfer single-channel ECG rhythms. It will also display ECG rhythms and detects the presence of atrial fibrillation.

The company noted that the heart monitor is intended for use by healthcare professionals, patients with known or suspected heart conditions and health conscious individuals.

Image: The latest version of the AliveECG app will help patients to detect AF in ECG recordings using the AliveCor Heart Monitor.